DEF: Surgery Partners Sets 2026 Annual Meeting Date

Surgery Partners, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 5, 2026, with April 8, 2026, as the record date for voting eligibility.

Summary

• Surgery Partners, Inc. is holding its 2026 Annual Meeting of Stockholders on June 5, 2026, at 10:00 a.m. Central Daylight Time.
• The meeting will be conducted virtually via remote communication.
• Stockholders of record as of April 8, 2026, are entitled to vote.
• Key items of business include the election of three Class II directors, an advisory vote on executive compensation, and ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
• The Board of Directors unanimously recommends voting 'FOR' all proposals.
• Proxy materials, including the Proxy Statement and Annual Report for the fiscal year ended December 31, 2025, are available online.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the explicit mention of 2025 results not meeting expectations and a significant net loss, despite the forward-looking statements about future growth.

Positives

• The company is holding its annual meeting to allow stockholders to vote on important corporate matters.
• The Board of Directors unanimously recommends favorable votes on all proposals, indicating alignment on key decisions.
• The company is providing clear instructions for virtual attendance and proxy voting, facilitating stockholder participation.
• The company is making proxy materials readily available online and offers paper copies upon request.

Negatives

• The company reported a net loss of $77.9 million for the fiscal year ended December 31, 2025, resulting in a net loss per share of $0.61.
• Adjusted EBITDA increased only 3.5% to $526.2 million in 2025, which may be considered modest given revenue growth.
• The Compensation Committee determined that no cash incentive award was earned by NEOs for 2025 due to performance metrics falling below threshold.

Risks

• The company's 2025 results did not meet expectations due to unanticipated headwinds.
• The staggered three-year terms for directors may delay or prevent a change in management or control.
• The company's stock price has experienced significant volatility, as indicated by the 'Pay Versus Performance' table showing a substantial decrease in the value of an initial $100 investment over several years.

Future Outlook

The company expresses confidence in its long-term growth potential and is shaping a plan for continued growth in 2026 and beyond, despite 2025 results not meeting expectations.

Management Comments

• We ended 2025 and entered 2026 with unanticipated headwinds that culminated in 2025 results that did not meet our expectations.
• We continue to have confidence in the Company's long-term growth potential and believe our NEOs are instrumental in proactively strengthening our performance, guiding the Company to capture momentum in the market and shaping a plan that will best position us for continued growth in 2026 and beyond.

Industry Context

StockSavvy.ai notes that Surgery Partners operates in the healthcare services sector, a dynamic industry influenced by regulatory changes, reimbursement policies, and evolving patient care models. The company's focus on surgical facilities and its performance metrics like revenue and Adjusted EBITDA are standard within this industry for assessing operational efficiency and profitability.

Comparison to Industry Standards

• The peer group for compensation benchmarking includes companies like Acadia Healthcare Company, Inc., Encompass Health Corporation, and Select Medical Holdings Corp, indicating Surgery Partners competes for talent and investor capital within the broader healthcare services and providers segment.
• The company's revenue growth of 6.2% in 2025, while positive, needs to be compared against industry-wide growth rates for ambulatory surgery centers and related healthcare facilities to determine if it is outperforming or lagging peers.
• The net loss reported for 2025 is a critical metric; industry-wide profitability trends for healthcare providers in the current economic climate would provide context for whether this loss is an anomaly or indicative of broader sector challenges.

Corporate Governance

Related Party Transactions

• The company has a Registration Rights Agreement with certain securityholders, including Bain Capital, for the registration of their shares.
• The company enters into indemnification agreements with its directors and executive officers.

Stakeholder Impact

• Shareholders: Will vote on director elections, executive compensation, and auditor ratification. Their investment value is impacted by the company's financial performance and outlook.
• Employees: The compensation discussion and analysis outlines incentive structures and benefits, impacting morale and retention.
• Management: Executive compensation is tied to performance metrics, with a significant portion being performance-based and at-risk.
• Auditors: Ernst & Young LLP is proposed for ratification as the independent registered public accounting firm, impacting financial reporting integrity.

Next Steps

• Stockholders are encouraged to vote their shares prior to the annual meeting.
• The company will announce preliminary voting results at the Annual Meeting and publish them in a Form 8-K within four business days.
• The company will file an amended Form 8-K if final voting results are not available at the time of the initial filing.

Key Dates

Recommendation

While the company is holding its annual meeting and proposing standard corporate actions, the explicit mention of 2025 results not meeting expectations, a net loss, and significant underperformance in the 'Pay Versus Performance' table suggest caution. The company's confidence in future growth is noted, but current financial performance and historical stock performance warrant a 'hold' until clearer signs of recovery and improved execution are demonstrated.

Keywords

Surgery Partners, Annual Meeting, Proxy Statement, Director Election, Executive Compensation, Independent Auditor, Stockholder Vote, Virtual Meeting, Corporate Governance